Back to Companies
GILEAD SCIENCES, INC.
GILDNasdaqCIK: 0000882095
GILEAD SCIENCES, INC. (GILD) shows 50 recent insider filings from 10 insiders, with all of them on the sell side. With $0 in purchases and $52.4M in sales, the recent tape is heavily weighted toward selling (net sales of $52.4M). O'Day Daniel Patrick (Chairman & CEO, Director) is the most active by dollar volume, and the single largest transaction was $32.6M by O'Day Daniel Patrick. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$104.9M
Purchases
$0
Sales
$52.4M
Unique Insiders
10
Recent Insider Trades
50 loaded
| Oct 2 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $2.2M |
| Sep 23 | GILD GILEAD SCIENCES, INC. | Burkhart Erin | SVP, Controllership | Exercise | $117.3K |
| Sep 16 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $435.9K |
| Sep 16 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $432.6K |
| Sep 11 | GILD GILEAD SCIENCES, INC. | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise | $41.3K |
| Sep 11 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Exercise | $612.5K |
| Sep 11 | GILD GILEAD SCIENCES, INC. | Berger Dietmar | Chief Medical Officer | Exercise | $38.1K |
| Sep 11 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Exercise | $195.1K |
| Sep 11 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise | $195.1K |
| Sep 2 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $2.2M |
| Aug 27 | GILD GILEAD SCIENCES, INC. | WELTERS ANTHONY | Director | Sell | $2.7M |
| Aug 21 | GILD GILEAD SCIENCES, INC. | Bluestone Jeffrey | Director | Sell | $725.1K |
| Aug 18 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $3.9M |
| Aug 18 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $415.1K |
| Aug 11 | GILD GILEAD SCIENCES, INC. | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise | $386.9K |
| Aug 4 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $2.0M |
| Jul 16 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $389.8K |
| Jul 16 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $389.8K |
| Jul 2 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $1.9M |
| Jun 16 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $376.2K |
| Jun 16 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $371.8K |
| Jun 11 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise | $162.9K |
| Jun 11 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Exercise | $511.8K |
| Jun 11 | GILD GILEAD SCIENCES, INC. | Berger Dietmar | Chief Medical Officer | Exercise | $31.9K |
| Jun 11 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Exercise | $162.9K |
| Jun 11 | GILD GILEAD SCIENCES, INC. | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise | $34.4K |
| Jun 2 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $2.0M |
| May 18 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $3.7M |
| May 18 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $396.8K |
| May 4 | GILD GILEAD SCIENCES, INC. | Bluestone Jeffrey | Director | Grant | $639.0K |
| May 4 | GILD GILEAD SCIENCES, INC. | MANWANI HARISH | Director | Grant | $668.3K |
| May 4 | GILD GILEAD SCIENCES, INC. | LOVE TED W | Director | Grant | $639.0K |
| May 4 | GILD GILEAD SCIENCES, INC. | WELTERS ANTHONY | Director | Grant | $639.0K |
| Apr 29 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $1.3M |
| Apr 16 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $422.9K |
| Apr 16 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $422.9K |
| Mar 30 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $1.4M |
| Mar 17 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $432.7K |
| Mar 17 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $432.7K |
| Mar 12 | GILD GILEAD SCIENCES, INC. | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Exercise | $2.9M |
| Mar 12 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Exercise | $5.8M |
| Mar 12 | GILD GILEAD SCIENCES, INC. | Berger Dietmar | Chief Medical Officer | Exercise | $4.8M |
| Mar 12 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Exercise | $5.8M |
| Mar 2 | GILD GILEAD SCIENCES, INC. | Berger Dietmar | Chief Medical Officer | Grant | $0 |
| Mar 2 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $1.4M |
| Mar 2 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Grant | $0 |
| Feb 18 | GILD GILEAD SCIENCES, INC. | Dickinson Andrew D | Chief Financial Officer | Sell | $463.3K |
| Feb 18 | GILD GILEAD SCIENCES, INC. | Mercier Johanna | Chief Comm & Corp Aff Officer | Sell | $4.3M |
| Feb 6 | GILD GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Chairman & CEO, Director | Sell | $17.3M |
| Feb 12 | GILD GILEAD SCIENCES, INC. | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Other | $0 |
50 filings+